Icahn School of Medicine at Mount Sinai-Clinical and Translational Research Center ( Site 0006)

New York, New York 10029

0 studies enrolling now · 1 studies all time

What they study most

HIV-1 Infection

Studies at this site

• Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033) — Running, not enrolling